Trial Profile
An open-label, expanded-access study of Fuzeon [enfuvirtide] plus an antiretroviral regimen to assess safety in patients with advanced HIV infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2010
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Roche
- 06 Jun 2006 New trial record.